| 000 | 02622 a2200709 4500 | ||
|---|---|---|---|
| 005 | 20250517024346.0 | ||
| 264 | 0 | _c20150817 | |
| 008 | 201508s 0 0 eng d | ||
| 022 | _a1097-685X | ||
| 024 | 7 |
_a10.1016/j.jtcvs.2015.01.065 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFrischknecht, Lukas | |
| 245 | 0 | 0 |
_aImportance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery. _h[electronic resource] |
| 260 |
_bThe Journal of thoracic and cardiovascular surgery _cJun 2015 |
||
| 300 |
_a1539-46.e1 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xanalysis |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aEndonucleases _xanalysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlutamates _xadministration & dosage |
| 650 | 0 | 4 |
_aGuanine _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aLung Neoplasms _xenzymology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMesothelioma _xenzymology |
| 650 | 0 | 4 | _aMesothelioma, Malignant |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPemetrexed |
| 650 | 0 | 4 |
_aPlatinum Compounds _xadministration & dosage |
| 650 | 0 | 4 |
_aPleural Neoplasms _xenzymology |
| 650 | 0 | 4 | _aPneumonectomy |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRibonucleoside Diphosphate Reductase |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTissue Array Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xanalysis |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aMeerang, Mayura | |
| 700 | 1 | _aSoltermann, Alex | |
| 700 | 1 | _aStahel, Rolf | |
| 700 | 1 | _aMoch, Holger | |
| 700 | 1 | _aSeifert, Burkhardt | |
| 700 | 1 | _aWeder, Walter | |
| 700 | 1 | _aOpitz, Isabelle | |
| 773 | 0 |
_tThe Journal of thoracic and cardiovascular surgery _gvol. 149 _gno. 6 _gp. 1539-46.e1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jtcvs.2015.01.065 _zAvailable from publisher's website |
| 999 |
_c24772617 _d24772617 |
||